Upper respiratory tract inflammation and Hyperkalemia

Summary:

Hyperkalemia is found among people with Upper respiratory tract inflammation, especially for people who are male, 60+ old.

The study analyzes which people have Hyperkalemia with Upper respiratory tract inflammation. It is created by eHealthMe based on reports of 14 people who have Upper respiratory tract inflammation from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Upper respiratory tract inflammation?

Upper respiratory tract inflammation is found to be associated with 369 drugs and 582 conditions by eHealthMe. Check the latest studies of Upper respiratory tract inflammation.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,956 drugs and 2,937 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On Jul, 26, 2026

14 people who have Upper Respiratory Tract Inflammation and Hyperkalemia are studied.

Would you have Hyperkalemia when you have Upper respiratory tract inflammation?

Gender of people who have Upper Respiratory Tract Inflammation and experienced Hyperkalemia *:

female: 28.57 %
male: 71.43 %

Age of people who have Upper Respiratory Tract Inflammation and experienced Hyperkalemia *:

Common co-existing conditions for these people *:

Back Pain: 3 people, 21.43%
Indigestion: 2 people, 14.29%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 2 people, 14.29%
Cardiac Failure: 2 people, 14.29%
Diarrhea: 2 people, 14.29%
Gastritis (inflammation of stomach): 2 people, 14.29%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 14.29%
Upper Respiratory Tract Infection: 2 people, 14.29%
Insomnia (sleeplessness): 2 people, 14.29%
Rashes (redness): 1 person, 7.14%

Common drugs taken by these people *:

Common symptoms for these people *:

Blood Lactate Dehydrogenase Increased: 5 people, 35.71%
Blood Creatinine Increased: 5 people, 35.71%
Aspartate Aminotransferase Increased: 5 people, 35.71%
Blood Urea Increased: 4 people, 28.57%
Gamma-Glutamyltransferase Increased: 4 people, 28.57%
Blood Alkaline Phosphatase Increased: 3 people, 21.43%
Blood Bilirubin Increased: 3 people, 21.43%
Cardiac Failure: 3 people, 21.43%
Blood Albumin Decreased: 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Upper respiratory tract inflammation (3,100 reports)
Hyperkalemia (78,084 reports)

All the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,956 drugs)

All the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,937 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperkalemia and Upper respiratory tract inflammation, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.